Detalhe da pesquisa
1.
Duration of Humoral Immunity and Cross-Neutralizing Activity Against the Alpha, Beta, and Delta Variants After Wild-Type Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Prospective Cohort Study.
J Infect Dis
; 226(6): 975-978, 2022 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172333